Dectin-2-mediated initiation of immune responses caused by influenza virus hemagglutinin. 2021

Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
Center for Transdisciplinary Research, Institute of Research Promotion,Niigata University.

Antigen-presenting cells express pattern recognition receptors (PRRs), which sense pathogen-associated molecular patterns from microorganisms and lead to the induction of inflammatory responses. C-type lectin receptors (CLRs), the representative PRRs, bind to microbial polysaccharides, among which Dectin-2 and Mincle recognize mannose-containing polysaccharides. Because influenza virus (IFV) hemagglutinin (HA) is rich in mannose polysaccharides, Dectin-2 or Mincle may contribute to the recognition of HA. In this study, we addressed the possible involvement of Dectin-2 and Mincle in the viral recognition and the initiation of cytokine production. Interleukin (IL)-12p40 and IL-6 production by bone marrow-derived dendritic cells (BM-DCs) upon stimulation with HA was significantly reduced in Dectin-2 knockout (KO) mice compared to wild-type (WT) mice whereas there was no difference between WT mice and Mincle KO mice. BM-DCs that were treated with Syk inhibitor resulted in a significant reduction of cytokine production upon stimulation with HA. The treatment of BM-DCs with methyl-α-D-mannopyranoside (ManP) also led to a significant reduction in cytokine production by BM-DCs that were stimulated with HA, except for the A/H1N1pdm09 subtype. IL-12p40 and IL-6 synthesis by BM-DCs was completely diminished upon stimulation with HA treated with concanavalin A (ConA)-bound sepharose beads. Finally, GFP expression was detected in reporter cells that were transfected with the Dectin-2 gene, but not with the Mincle gene, when stimulated with HA derived from the A/H3N2 subtype. These data suggested that Dectin-2 may be a key molecule as the sensor for IFV to initiate the immune response and regulate the pathogenesis of IFV infection.

UI MeSH Term Description Entries
D007107 Immune System The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components. Immune Systems,System, Immune,Systems, Immune
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072377 Syk Kinase An SH2 domain-containing non-receptor tyrosine kinase that regulates signal transduction downstream of a variety of receptors including B-CELL ANTIGEN RECEPTORS. It functions in both INNATE IMMUNITY and ADAPTIVE IMMUNITY and also mediates signaling in CELL ADHESION; OSTEOGENESIS; PLATELET ACTIVATION; and vascular development. SYK Tyrosine Kinase,Spleen Tyrosine Kinase,Kinase, SYK Tyrosine,Kinase, Spleen Tyrosine,Kinase, Syk,Tyrosine Kinase, SYK,Tyrosine Kinase, Spleen

Related Publications

Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
June 2012, Acta pharmacologica Sinica,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
January 1980, Immunological communications,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
May 2007, Vaccine,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
July 1979, Infection and immunity,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
January 2018, Viral immunology,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
October 1986, Microbial pathogenesis,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
November 1981, The Journal of experimental medicine,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
January 1997, Vaccine,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
January 1990, Annual review of immunology,
Hideki Yamamoto, and Chikako Tomiyama, and Ko Sato, and Jun Kasamatsu, and Kazuki Takano, and Aya Umeki, and Nana Nakahata, and Tomomitsu Miyasaka, and Emi Kanno, and Hiromasa Tanno, and Sho Yamasaki, and Shinobu Saijo, and Yoichiro Iwakura, and Keiko Ishii, and Kazuyoshi Kawakami
January 2018, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!